Dose‐response relationship between sulfonylureas and major adverse cardiovascular events in elderly patients with type 2 diabetes

ConclusionsAmong new users of sulfonylureas, there appears to be a dose‐response relationship between glyburide and MACE, but not for gliclazide. Copyright © 2016 John Wiley & Sons, Ltd.

Source: Pharmacoepidemiology and Drug Safety - April 21, 2016 Category: Drugs & Pharmacology Authors: Ahmed S. Abdelmoneim, Dean T. Eurich, Ambikaipakan Senthilselvan, Weiyu Qiu, Scot H. Simpson Tags: Original Report Source Type: research